Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.28885
+0.00085 (0.30%)
At close: Aug 28, 2026
Elite Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 56.67 | 44.87 | -4.31 | 20.11 | 3.56 | 8.9 |
Depreciation & Amortization | 2 | 2.02 | 2.12 | 1.52 | 1.33 | 1.42 |
Other Amortization | 0.01 | 0.01 | 0.01 | - | 0.01 | 0.01 |
Loss (Gain) From Sale of Assets | - | - | 0.12 | - | - | - |
Asset Writedown & Restructuring Costs | 0.85 | 0.85 | 1.6 | - | 0.29 | - |
Stock-Based Compensation | 0.15 | 0.18 | 0.23 | 6.75 | 0.58 | 0.78 |
Provision & Write-off of Bad Debts | 0.68 | 1.05 | 0.15 | 0.24 | - | - |
Other Operating Activities | -23.08 | 2.69 | 22.7 | -19.96 | -0.43 | -3.6 |
Change in Accounts Receivable | -14.9 | -31.56 | -9.9 | -16.6 | -0.04 | 0.44 |
Change in Inventory | -4.84 | -5.02 | -3.31 | -3.38 | -2.81 | -1.73 |
Change in Accounts Payable | 0.5 | 3.1 | 0.24 | 0.02 | 1.34 | 0.31 |
Change in Unearned Revenue | -0 | -0.01 | -0.01 | -0.01 | - | -0.01 |
Change in Other Net Operating Assets | 1 | 5.57 | -2.18 | 8.07 | -0.5 | -0.02 |
Operating Cash Flow | 19.04 | 23.75 | 7.46 | -3.24 | 3.34 | 6.51 |
Operating Cash Flow Growth | -0.24% | 218.52% | - | - | -48.70% | 103.78% |
Investing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -1.52 | -0.93 | -1.63 | -0.81 | -5.74 | -0.5 |
Sale of Property, Plant & Equipment | - | - | 0.13 | - | - | - |
Sale (Purchase) of Intangibles | - | - | -0.9 | - | - | - |
Investing Cash Flow | -1.52 | -0.93 | -2.4 | -0.81 | -5.74 | -0.5 |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | - | - | 4 | - | - |
Long-Term Debt Issued | - | - | - | - | 14.44 | - |
Total Debt Issued | - | - | - | 4 | 14.44 | - |
Short-Term Debt Repaid | - | -4 | - | - | - | - |
Long-Term Debt Repaid | - | -0.64 | -0.85 | -0.66 | -12.74 | -0.67 |
Total Debt Repaid | -0.63 | -4.64 | -0.85 | -0.66 | -12.74 | -0.67 |
Net Debt Issued (Repaid) | -0.63 | -4.64 | -0.85 | 3.34 | 1.7 | -0.67 |
Issuance of Common Stock | 0.32 | 0.32 | 0.02 | - | - | - |
Financing Cash Flow | -0.31 | -4.32 | -0.83 | 3.34 | 1.7 | -0.67 |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | 17.22 | 18.5 | 4.23 | -0.71 | -0.7 | 5.34 |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 17.53 | 22.82 | 5.83 | -4.04 | -2.4 | 6.01 |
Free Cash Flow Growth | -2.76% | 291.43% | - | - | - | 109.85% |
Free Cash Flow Margin | 12.43% | 15.33% | 6.94% | -7.14% | -7.02% | 18.63% |
Free Cash Flow Per Share | 0.01 | 0.02 | 0.01 | -0.00 | -0.00 | 0.01 |
Levered Free Cash Flow | 23 | 5.87 | -2.18 | -4.87 | -4.55 | 3.6 |
Unlevered Free Cash Flow | 23.18 | 6.1 | -1.71 | -4.5 | -3.87 | 3.71 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 0.11 | 0.25 | 0.67 | 0.12 | 1.1 | 0.18 |
Cash Income Tax Paid | 1.17 | 1.15 | 0.61 | 0.29 | 0.42 | - |
Change in Working Capital | -18.24 | -27.92 | -15.17 | -11.89 | -2.01 | -1.01 |